In this section
Clinical trials
- Participate in a clinical trial
- For medical professionals
- Active clinical trials for pediatric cancers
- CAR-20/19-T cells in pediatric and young adult patients with relapsed/refractory B Cell Acute Lymphoblastic Leukemia (CAR-20/19-T) phase 1 clinical trial
- Unrelated and partially matched related donor peripheral stem cell transplantation for patients with hematologic malignancies clinical trial
- Early stage research
Active clinical trials
Cancer Clinical Trials - COG-ARST2032
Protocol Summary
- Protocol No
- COG-ARST2032
- Principal Investigator
- Kerri Becktell
- Phase
- III
- Title
- A Prospective Phase III Study of Patients with Newly Diagnosed Very Low-Risk and Low-Risk Fusion Negative Rhabdomyosarcoma
- Associated Disease(s)
-
Rhabdomyosarcoma
- Description (Summary)
- The overall goals of this study are:
1. To compare the effects, good and/or bad, of giving less chemotherapy drugs to people with VLR-RMS to find out which is better. This is Arm VLR-RMS of the study.
2. To find out how well people with LR-RMS as a group respond to standard chemotherapy when risk groups are refined so that people with VLR-RMS and people who have RMS with DNA mutations are removed from the LR group and get separate treatment. This is Arm LR-RMS of the study.
3. To describe the effects, good and/or bad, of giving chemotherapy drugs for longer amount of time to people who have RMS cancer with DNA mutations to see if they benefit from longer therapy than if they continued on VLR or LR therapy. This is Arm M of the study.
- Participating Institutions
- Childrens Hospital of Wisconsin
- ClinicalTrials.gov
Contact us
For more information about cancer and blood disorders clinical trials, email us or call
(414) 955-4727
Get a second opinion
It's important to know what your options are. We can provide expert opinions to verify or give more information about an initial diagnosis. Contact us today.
Why participate in clinical trials?
